Bio Integrates 2023
Registration & Networking
08:20 – 09:10
Registration and networking
Welcome & Opening Remarks
09:10 – 09:20
Welcome & Opening Remarks
Martino Picardo | Chairman | Discovery Park
Fireside Chat
09:20 – 10:00
Fireside Chat
Camilla Easter | Chief Executive Officer | Oxford Medical Products
Vineeta Tripathi | Chief Executive Officer, Chief Scientific Officer | Vitarka Therapeutics
Lydia Mapstone | Chief Executive Officer and Co-founder | BoobyBiome
Interviewed by
Martino Picardo | Chairman | Discovery Park
PLATFORM
Spotlight on what helps underpin a biotech’s success beyond the core innovation
PLANNING
Everything else that is important to success that’s not the science!
PREDICTION
If only we all had a crystal ball…
Session 1
10:05 – 10:55
Formulations – what’s new and do I need to be there?
What’s the latest and greatest supporting targeting and personalisation. How do you choose the best option?
Walking the antibody catwalk
Therapeutic antibody design and engineering – is this modality still relevant – is C> taking over, or is there a resurgence of small molecules?
Location, location, location
How much impact does this have on your success? How to choose the right site for your business.
Session 2
11:00 – 11:50
All aboard the data express!
Accessing data is vital, how do you choose the right way to do it? Infrastructure and data sources – choosing the right ones
Growing in a time of drought
Getting investment to grow your business; fundraising in a tough environment
To AI or not to AI? That’s the question…
Is AI helpful to all biotechs? When to apply it, how to apply it, do you know what it is?
Networking
11:50 – 12:20
Networking Coffee
Session 3
12:20- 13:10
Do you need a platform to maximise the value of IP?
Is a platform where it is at – must I have one to get investment? How to manage a platform in terms of focus of effort and POC, etc.
Tick tock, tick tock …
Scaling up – I’ve got my investment, now how do I deliver the next milestones quickly? Including team, manufacturing, capacity & making it happen.
Get it right first time
How to decide the right [partnering] strategy to overcome the challenges of getting a first-in-class / new therapeutic modality to the market first time.
Networking
13:10 – 14:10
Networking Lunch
Session 4
14:10 – 15:00
No Session in this Track
Please choose an alternative track
Managing your partners
Managing your CDMO and CRO partners to get the slots you need when you need them – does a small entity have any leverage?
Fishing in a bigger pond – how to reel in the money
As tech and other investors, including general/retail, look to biotech and the Life Sciences, how does biotech compete with other LS sectors – and how do you keep these investors happy?
Session 5
15:05 – 15:55
What makes the best platform?
What should it look like in order to deliver the best value/return/success?
No Session in this Track
Please choose an alternative track
Emerging technologies for improving drug and vaccine development for infectious disease
How quickly is the discovery landscape shifting towards new modalities and what challenges do these present for the clinical trials and regulatory systems?
Has the way we handled COVID therapeutics generated long term change in the discovery, development and regulatory systems?
Networking
15:55– 16:55
Drinks Reception
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.
Bio Integrates 2023
Registration & Networking
08:20 – 09:10
Fireside Chat
09:20 – 10:00
Camilla Easter | Chief Executive Officer | Oxford Medical Products
Vineeta Tripathi | Chief Executive Officer, Chief Scientific Officer | Vitarka Therapeutics
Lydia Mapstone | Chief Executive Officer and Co-founder | BoobyBiome
Interviewed by
Martino Picardo | Chairman | Discovery Park
PLATFORM
Spotlight on what helps underpin a biotech’s success beyond the core innovation
Session 1
10:05 – 10:55
Formulations – what’s new and do I need to be there?
What’s the latest and greatest supporting targeting and personalisation. How do you choose the best option?
Session 2
11:00 – 11:50
All aboard the data express!
Accessing data is vital, how do you choose the right way to do it? Infrastructure and data sources – choosing the right ones
Networking Coffee
11:50 – 12:20
Session 3
12:20- 13:10
Do you need a platform to maximise the value of IP?
Is a platform where it is at – must I have one to get investment? How to manage a platform in terms of focus of effort and POC, etc.
Networking Lunch
13:10 – 14:10
Session 5
15:05 – 15:55
What makes the best platform?
What should it look like in order to deliver the best value/return/success?
Networking Drinks Reception
15:55– 16:55
PLANNING
Everything else that is important to success that’s not the science!
Session 1
10:05 – 10:55
Walking the antibody catwalk
Therapeutic antibody design and engineering – is this modality still relevant – is C> taking over, or is there a resurgence of small molecules?
Session 2
11:00 – 11:50
Growing in a time of drought
Getting investment to grow your business; fundraising in a tough environment
Networking Coffee
11:50 – 12:20
Session 3
12:20- 13:10
Tick tock, tick tock …
Scaling up – I’ve got my investment, now how do I deliver the next milestones quickly? Including team, manufacturing, capacity & making it happen.
Networking Lunch
13:10 – 14:10
Session 4
14:10 – 15:00
Managing your partners
Managing your CDMO and CRO partners to get the slots you need when you need them – does a small entity have any leverage?
Networking Drinks Reception
15:55– 16:55
PREDICTION
If only we all had a crystal ball…
Session 1
10:05 – 10:55
Location, location, location
How much impact does this have on your success? How to choose the right site for your business.
Session 2
11:00 – 11:50
To AI or not to AI? That’s the question…
Is AI helpful to all biotechs? When to apply it, how to apply it, do you know what it is?
Networking Coffee
11:50 – 12:20
Session 3
12:20- 13:10
Get it right first time
How to decide the right [partnering] strategy to overcome the challenges of getting a first-in-class / new therapeutic modality to the market first time.
Networking Lunch
13:10 – 14:10
Session 4
14:10 – 15:00
Fishing in a bigger pond – how to reel in the money
As tech and other investors, including general/retail, look to biotech and the Life Sciences, how does biotech compete with other LS sectors – and how do you keep these investors happy?
Session 5
15:05 – 15:55
Emerging technologies for improving drug and vaccine development for infectious disease
How quickly is the discovery landscape shifting towards new modalities and what challenges do these present for the clinical trials and regulatory systems?
Has the way we handled COVID therapeutics generated long term change in the discovery, development and regulatory systems?
Networking Drinks Reception
15:55– 16:55
Sign up for life science integrates news
Get the latest news and updates by signing up today.
By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.